- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
Patent holdings for IPC class A61K 31/138
Total number of patents in this class: 2170
10-year publication summary
|
169
|
162
|
178
|
184
|
252
|
196
|
177
|
152
|
153
|
95
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Antecip Bioventures II LLC | 374 |
66 |
| Apnimed, Inc. (Delaware) | 62 |
33 |
| Atossa Therapeutics, Inc. | 77 |
25 |
| Genentech, Inc. | 4099 |
24 |
| Novartis AG | 10263 |
23 |
| The Regents of the University of California | 20720 |
21 |
| Duke University | 3184 |
20 |
| Ohemo Life Sciences Inc | 23 |
18 |
| Jina Pharmaceuticals, Inc. | 35 |
17 |
| Pharnext | 80 |
17 |
| Curasen Therapeutics, Inc. | 51 |
17 |
| Saniona A/S | 53 |
16 |
| Emory University | 1719 |
15 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3299 |
15 |
| Actimed Therapeutics Limited | 28 |
15 |
| The Board of Trustees of the University of Illinois | 2750 |
14 |
| Clexio Biosciences Ltd. | 100 |
13 |
| Centre National de La Recherche Scientifique | 11016 |
11 |
| Nalpropion Pharmaceuticals LLC | 68 |
11 |
| The Procter & Gamble Company | 21861 |
10 |
| Other owners | 1769 |